Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Argatroban Monotherapy vs Argatroban-Edaravone Combination Therapy in Acute Ischemic Stroke
NCT00153946Phase 4Completed
- Sponsor
- Combination Therapy for Acute Ischemic Stroke Study Group
- Start
- Aug 2004
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of edaravone in ischemic stroke (2 arms), sponsored by Combination Therapy for Acute Ischemic Stroke Study Group. Primary endpoints: Modified Rankin Scale at 3 months and Symptomatic intracranial hemorrhage at 3 weeks. Started Aug 2004; status: completed.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT00153946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00153946.